Key result
Higher GGT and phosphorus levels linked to increased 1-month mortality in ACS.
Why the study?
Serum GGT, calcium, and inorganic phosphorus levels may have prognostic value for short-term mortality after myocardial infarction, but their roles are not well established.
Cohort (n=200)
No
Answers are grounded in this paper and cite their sources.
Objective: Gamma-glutamyltransferase (GGT) may be considered as a biomarker of “oxidative stress” associated with glutathione metabolism and a possible “proatherogenic” marker because of its indirect relationship with the biochemical steps in the oxidation of low density lipoprotein cholesterol. Serum inorganic phosphorus (P) level is also suggested as an independent risk factor for cardiac events and mortality in the long term. We aimed to observe the relationship of serum GGT, calcium (Ca), and P levels with 1 months’ mortality after myocardial infarction.Methods: Our retrospective study included 200 patients (124 men and 76 women) with acute coronary syndrome (ACS) who were admitted to our hospital. We excluded subjects with severe systemic illness, hepatobiliary disease, alcohol consumption, chronic metabolic bone disease, malignancy, parathyroid disease, and patients who had a glomerular filtration rate (GFR) <60 mL/min. Fasting blood samples were taken in the first 24 h of admission to the coronary care unit (CCU). Reference values for GGT (9-36 U/L, for women; 12-64 U/L, for men), Ca (8.4-10.2 mg/dL), and inorganic P (≤4.5 mg/dL) were used. When the serum albumin level was <4.0 g/dL, corrected Ca levels were calculated using the equation [corrected Ca=measured Ca+(0.8×(4-serum albumin)]. Statistical analysis was performed using SPSS for Windows 10.0. Descriptive statistical analysis, Student’s t-test, Mann-Whitney U-test, and chi-square test were used.Results: At the end of 1 month, we found significantly higher levels of blood GGT, P, and Ca×P products in patients who did not survive (n=23; 32.9 U/L, 3.66 mg/dL, 35.93 mg2/dL2) than in survivors (n=177; 24.16 U/L, 3.27 mg/dL, 31.57 mg2/dL2; p<0.001, p<0.001, p<0.001, respectively).Conclusion: Serum GGT, P, and Ca×P levels, even in the reference intervals, had a prognostic value in the short-term mortality apart from traditional risk factors such as diabetes mellitus, hypertension, and ischemic heart disease. This study also suggests constituting new reference values for this high risk population in stratifying patient risk and in assessing the intensity of appropriate treatment, with hopes of preventing cardiac deaths.
No takes yet. Share an insight, caveat, or question.
Ergen et al. (2015) conducted a cohort in Acute Coronary Syndrome (n=200). Serum gamma-glutamyltransferase (GGT), phosphorus, and Ca×P product levels vs. Survivors (lower biomarker levels) was evaluated on Mean serum GGT levels (U/L) in non-survivors vs survivors at 1 month (p=<0.001). In patients with acute coronary syndrome, those who did not survive at 1 month had significantly higher baseline levels of serum GGT (32.96 vs 24.16 U/L), phosphorus (3.66 vs 3.27 mg/dL), and Ca×P products (35.93 vs 31.57 mg2/dL2) compared to survivors.
Synapse has enriched 10 related papers. Consider them for comparative context: